Last reviewed · How we verify
DISC-0974
At a glance
| Generic name | DISC-0974 |
|---|---|
| Sponsor | Disc Medicine, Inc |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of DISC-0974-201 in Participants With IBD and Anemia (PHASE2)
- Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia (PHASE1, PHASE2)
- Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia (PHASE1)
- Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DISC-0974 CI brief — competitive landscape report
- DISC-0974 updates RSS · CI watch RSS
- Disc Medicine, Inc portfolio CI